Search Results

There are 9297 results for: content related to: Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure

  1. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys

    Journal of Neuroscience Research

    Volume 87, Issue 2, 1 February 2009, Pages: 586–597, Pablo Garrido-Gil, Silvia Belzunegui, Waldy San Sebastián, Amaya Izal-Azcárate, Berta López, Irene Marcilla and Maria Rosario Luquin

    Version of Record online : 16 SEP 2008, DOI: 10.1002/jnr.21845

  2. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  3. You have free access to this content
    Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Journal of Neurochemistry

    Volume 122, Issue 5, September 2012, Pages: 1032–1046, Sophie Schumm, Claude Sebban, Charles Cohen-Salmon, Jacques Callebert, Jean-Marie Launay, Jean-Louis Golmard, Lydie Boussicault, Isabelle Petropoulos, Audrey Hild, Estelle Rousselet, Annick Prigent, Bertrand Friguet, Jean Mariani and Etienne C. Hirsch

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1471-4159.2012.07837.x

  4. You have free access to this content
    Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions

    Journal of Neurochemistry

    Volume 109, Issue 5, June 2009, Pages: 1469–1482, Claire Gibrat, Martine Saint-Pierre, Mélanie Bousquet, Daniel Lévesque, Claude Rouillard and Francesca Cicchetti

    Version of Record online : 28 MAR 2009, DOI: 10.1111/j.1471-4159.2009.06072.x

  5. Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression

    Journal of Comparative Neurology

    Volume 504, Issue 6, 20 October 2007, Pages: 690–701, Gilmor I. Keshet, Ravi J. Tolwani, Angelica Trejo, Peggy Kraft, Regis Doyonnas, Carol Clayberger, James M. Weimann and Helen M. Blau

    Version of Record online : 22 AUG 2007, DOI: 10.1002/cne.21483

  6. You have free access to this content
    Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α-synuclein

    Journal of Neuroscience Research

    Volume 94, Issue 1, January 2016, Pages: 62–73, Johannes C.M. Schlachetzki, Thomas Grimm, Zinayida Schlachetzki, Nada M.B. Ben Abdallah, Benjamin Ettle, Patrizia Vöhringer, Boris Ferger, Beate Winner, Silke Nuber and Jürgen Winkler

    Version of Record online : 9 OCT 2015, DOI: 10.1002/jnr.23677

  7. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice

    Journal of Neurochemistry

    Volume 136, Issue 2, January 2016, Pages: 373–387, Ana B. Muñoz-Manchado, Javier Villadiego, Sonia Romo-Madero, Nela Suárez-Luna, Alfonso Bermejo-Navas, José A. Rodríguez-Gómez, Pablo Garrido-Gil, José L. Labandeira-García, Miriam Echevarría, José López-Barneo and Juan J. Toledo-Aral

    Version of Record online : 24 NOV 2015, DOI: 10.1111/jnc.13409

  8. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress

    European Journal of Neuroscience

    Volume 28, Issue 1, July 2008, Pages: 41–50, Patricia Rojas, Norma Serrano-García, José J. Mares-Sámano, Omar Noel Medina-Campos, José Pedraza-Chaverri and Sven Ove Ögren

    Version of Record online : 4 JUL 2008, DOI: 10.1111/j.1460-9568.2008.06314.x

  9. You have free access to this content
    The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

    Journal of Neurochemistry

    Volume 76, Issue 5, March 2001, Pages: 1265–1274, Serge Przedborski, Vernice Jackson-Lewis, Ali B. Naini, Michael Jakowec, Giselle Petzinger, Reginald Miller and Muhammad Akram

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00183.x

  10. You have free access to this content
    VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease

    Journal of Neurochemistry

    Volume 105, Issue 1, April 2008, Pages: 78–90, Ming-Kai Chen, Hiroto Kuwabara, Yun Zhou, Robert J. Adams, James R. Brašić, Jennifer L. McGlothan, Tatyana Verina, Neal C. Burton, Mohab Alexander, Anil Kumar, Dean F. Wong and Tomás R. Guilarte

    Version of Record online : 6 NOV 2007, DOI: 10.1111/j.1471-4159.2007.05108.x

  11. You have free access to this content
    Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression

    Journal of Neurochemistry

    Volume 98, Issue 2, July 2006, Pages: 495–505, Jeffrey M. Brown, Shawn Gouty, Varsha Iyer, John Rosenberger and Brian M. Cox

    Version of Record online : 2 JUN 2006, DOI: 10.1111/j.1471-4159.2006.03902.x

  12. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins

    Journal of Neuroscience Research

    Volume 83, Issue 2, 1 February 2006, Pages: 332–347, Giselle M. Petzinger, Beth Fisher, Elizabeth Hogg, Avery Abernathy, Pablo Arevalo, Kerry Nixon and Michael W. Jakowec

    Version of Record online : 29 DEC 2005, DOI: 10.1002/jnr.20730

  13. Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

    Journal of Neuroscience Research

    Volume 88, Issue 7, 15 May 2010, Pages: 1522–1536, Hironori Yokoyama, Hayato Kuroiwa, Tatsuya Tsukada, Hiroto Uchida, Hiroyuki Kato and Tsutomu Araki

    Version of Record online : 8 DEC 2009, DOI: 10.1002/jnr.22310

  14. Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons

    Journal of Neuroscience Research

    Volume 89, Issue 3, March 2011, Pages: 406–417, James A. Miller, Briana R. Trout, Kelly A. Sullivan, Russell A. Bialecki, Ruth A. Roberts and Ronald B. Tjalkens

    Version of Record online : 6 JAN 2011, DOI: 10.1002/jnr.22549

  15. Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease

    Glia

    Volume 64, Issue 9, September 2016, Pages: 1590–1604, Bevan S. Main, Moses Zhang, Kate M. Brody, Scott Ayton, Tony Frugier, David Steer, David Finkelstein, Peter J. Crack and Juliet M. Taylor

    Version of Record online : 12 JUL 2016, DOI: 10.1002/glia.23028

  16. You have free access to this content
    Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway

    Journal of Neurochemistry

    Volume 97, Issue 4, May 2006, Pages: 1126–1135, Xichuan Teng, Takashi Sakai, Li Liu, Rika Sakai, Ryuji Kaji and Kiyoshi Fukui

    Version of Record online : 25 APR 2006, DOI: 10.1111/j.1471-4159.2006.03833.x

  17. You have free access to this content
    Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease

    Journal of Neurochemistry

    Volume 82, Issue 3, August 2002, Pages: 615–624, T. Breidert, J. Callebert, M. T. Heneka, G. Landreth, J. M. Launay and E. C. Hirsch

    Version of Record online : 24 JUL 2002, DOI: 10.1046/j.1471-4159.2002.00990.x

  18. You have free access to this content
    Genetic ablation of tumor necrosis factor-alpha (TNF-α) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum

    Journal of Neurochemistry

    Volume 89, Issue 4, May 2004, Pages: 822–833, Boris Ferger, Andreas Leng, Anna Mura, Bastian Hengerer and Joram Feldon

    Version of Record online : 19 APR 2004, DOI: 10.1111/j.1471-4159.2004.02399.x

  19. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  20. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688